8-KLeadership Changes

CVS HEALTH Corp 8-K Report, Executive Changes (Sep 21, 2023)

Filed September 21, 2023For Securities:CVS

Summary

CVS Health Corporation (CVS) announced a significant addition to its Board of Directors with the election of Michael F. Mahoney, effective November 1, 2023. Mr. Mahoney brings a wealth of experience from the medical device and healthcare industries, having held prominent leadership roles including President and CEO of Boston Scientific and various executive positions at Johnson & Johnson and General Electric. His appointment is expected to strengthen the board's expertise in the healthcare sector. Investors should note that Mr. Mahoney has a proven track record in driving growth and innovation within complex healthcare organizations. His prior board experience, including his recent tenure at Baxter International, suggests a familiarity with corporate governance and strategic oversight. The company has affirmed Mr. Mahoney's independence, aligning with NYSE listing standards, and his compensation will be in line with existing non-employee director practices.

Key Highlights

  • 1CVS Health has appointed Michael F. Mahoney to its Board of Directors, effective November 1, 2023.
  • 2Mr. Mahoney is a seasoned executive with extensive experience in the healthcare and medical device sectors.
  • 3He currently serves as President, CEO, and Chairman of Boston Scientific, a major global medical device company.
  • 4Mr. Mahoney has prior leadership roles at Johnson & Johnson's DePuy franchise and General Electric Medical Systems.
  • 5His appointment is considered an "independent" director under NYSE and CVS Health's governance guidelines.
  • 6Mr. Mahoney previously served on the Board of Directors for Baxter International Inc. from 2015 to 2023.
  • 7His compensation as a director will be consistent with other non-employee directors at CVS Health.

Frequently Asked Questions

Michael F. Mahoney is a highly experienced executive in the healthcare industry. He has served as President, CEO, and Chairman of Boston Scientific Corporation, a leading medical device company, since 2011. His career also includes significant leadership roles at Johnson & Johnson, General Electric Medical Systems, and Global Healthcare Exchange.

The appointment of Mr. Mahoney brings deep industry expertise and a strong leadership background to CVS Health's Board of Directors. His experience in a prominent medical device company like Boston Scientific can provide valuable strategic insights and oversight, potentially contributing to the company's growth and operational effectiveness.

Yes, the Board of Directors has determined that Mr. Mahoney is an independent director, meeting the requirements of the New York Stock Exchange's Corporate Governance Rules and CVS Health's own Corporate Governance Guidelines.

Mr. Mahoney's compensation for his service as a non-employee director will be consistent with that of CVS Health's other non-employee directors. It will be prorated to reflect his start date on the Board.